Get the Stockscreener App
14.00
3.78%
0.51
After Hours:
13.72
-0.28
-2.00%
Gh Research Plc stock is traded at $14.00, with a volume of 183.34K.
It is up +3.78% in the last 24 hours and up +5.03% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$13.49
Open:
$13.6
24h Volume:
183.34K
Relative Volume:
0.64
Market Cap:
$728.39M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-17.72
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
+8.02%
1M Performance:
+5.03%
6M Performance:
+53.85%
1Y Performance:
+68.47%
1-Day Range:
$13.60
$14.32
1-Week Range:
$12.69
$14.90
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.00 | 836.78M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.10 | 106.87B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
491.22 | 63.14B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.77 | 61.27B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
849.46 | 51.94B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
167.91 | 35.04B | 398.11M | -1.03B | -868.57M | -5.7032 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Visual analytics tools that track GH Research PLC performance2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Is GH Research PLC (1KA) stock considered safe havenWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Has GH Research PLC formed a bullish divergence2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
Is GH Research PLC showing signs of accumulationJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com
Is GH Research PLC stock a safe buy before earningsTreasury Yields & AI Powered Market Entry Strategies - newser.com
Will GH Research PLC (1KA) stock see valuation expansionJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com
What’s next for GH Research PLC stock priceMarket Sentiment Report & Daily Stock Trend Reports - newser.com
Order flow analysis tools used on GH Research PLCGDP Growth & Reliable Momentum Entry Alerts - newser.com
Real time alert setup for GH Research PLC performanceQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Can a trend reversal in GH Research PLC lead to recoveryJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
How risky is GH Research PLC stock nowJuly 2025 Snapshot & Technical Confirmation Trade Alerts - nchmf.gov.vn
(GHRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How supply chain issues affect GH Research PLC stockMarket Performance Report & Daily Stock Trend Watchlist - nchmf.gov.vn
Is GH Research PLC stock a buy in volatile markets2025 Support & Resistance & Real-Time Chart Breakout Alerts - nchmf.gov.vn
GH Research’s GH001 Trial Results to be Presented at ACNP Meeting - TipRanks
What momentum shifts mean for GH Research PLCJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
GH Research Presents Promising GH001 Trial Data at ECNP 2025 - MSN
How GH Research PLC stock responds to policy changesWeekly Trend Report & Low Drawdown Momentum Ideas - newser.com
Will GH Research PLC stock outperform international peersJuly 2025 Chart Watch & Low Drawdown Investment Ideas - newser.com
Using fundamentals and technicals on GH Research PLC2025 Valuation Update & Growth-Oriented Investment Plans - newser.com
GH Research Unveils Promising GH001 Trial Data at ECNP 2025 - TipRanks
Is GH Research PLC stock attractive for income investorsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Has GH Research PLC found a price floor2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga
Is GH Research PLC stock cheap at current valuationDay Trade & AI Driven Stock Price Forecasts - newser.com
Combining machine learning predictions for GH Research PLCJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq
Signal strength of GH Research PLC stock in tech scannersMarket Risk Report & Verified Short-Term Plans - newser.com
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire
GH Research PLC stock momentum explainedMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
2.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):